Global Age Related Macular Degeneration Drug Sales Market Report 2016

Global Age Related Macular Degeneration Drug Sales Market Report 2016

1 Age Related Macular Degeneration Drug Overview

1.1 Product Overview and Scope of Age Related Macular Degeneration Drug

1.2 Classification of Age Related Macular Degeneration Drug

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Age Related Macular Degeneration Drug

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 Age Related Macular Degeneration Drug Market by Regions

1.4.1 USA Status and Prospect (2011-2021)

1.4.2 China Status and Prospect (2011-2021)

1.4.3 Europe Status and Prospect (2011-2021)

1.4.4 Japan Status and Prospect (2011-2021)

1.4.5 India Status and Prospect (2011-2021)

1.4.6 Southeast Asia Status and Prospect (2011-2021)

1.5 Global Market Size (Value and Volume) of Age Related Macular Degeneration Drug (2011-2021)

1.5.1 Global Age Related Macular Degeneration Drug Sales and Growth Rate (2011-2021)

1.5.2 Global Age Related Macular Degeneration Drug Revenue and Growth Rate (2011-2021)

2 Global Age Related Macular Degeneration Drug Competition by Manufacturers, Type and Application

2.1 Global Age Related Macular Degeneration Drug Market Competition by Manufacturers

2.1.1 Global Age Related Macular Degeneration Drug Sales and Market Share of Key Manufacturers (2011-2016)

2.1.2 Global Age Related Macular Degeneration Drug Revenue and Share by Manufacturers (2011-2016)

2.2 Global Age Related Macular Degeneration Drug (Volume and Value) by Type

2.2.1 Global Age Related Macular Degeneration Drug Sales and Market Share by Type (2011-2016)

2.2.2 Global Age Related Macular Degeneration Drug Revenue and Market Share by Type (2011-2016)

2.3 Global Age Related Macular Degeneration Drug (Volume and Value) by Regions

2.3.1 Global Age Related Macular Degeneration Drug Sales and Market Share by Regions (2011-2016)

2.3.2 Global Age Related Macular Degeneration Drug Revenue and Market Share by Regions (2011-2016)

2.4 Global Age Related Macular Degeneration Drug (Volume) by Application

3 USA Age Related Macular Degeneration Drug (Volume, Value and Sales Price)

3.1 USA Age Related Macular Degeneration Drug Sales and Value (2011-2016)

3.1.1 USA Age Related Macular Degeneration Drug Sales and Growth Rate (2011-2016)

3.1.2 USA Age Related Macular Degeneration Drug Revenue and Growth Rate (2011-2016)

3.1.3 USA Age Related Macular Degeneration Drug Sales Price Trend (2011-2016)

3.2 USA Age Related Macular Degeneration Drug Sales and Market Share by Manufacturers

3.3 USA Age Related Macular Degeneration Drug Sales and Market Share by Type

3.4 USA Age Related Macular Degeneration Drug Sales and Market Share by Application

4 China Age Related Macular Degeneration Drug (Volume, Value and Sales Price)

4.1 China Age Related Macular Degeneration Drug Sales and Value (2011-2016)

4.1.1 China Age Related Macular Degeneration Drug Sales and Growth Rate (2011-2016)

4.1.2 China Age Related Macular Degeneration Drug Revenue and Growth Rate (2011-2016)

4.1.3 China Age Related Macular Degeneration Drug Sales Price Trend (2011-2016)

4.2 China Age Related Macular Degeneration Drug Sales and Market Share by Manufacturers

4.3 China Age Related Macular Degeneration Drug Sales and Market Share by Type

4.4 China Age Related Macular Degeneration Drug Sales and Market Share by Application

5 Europe Age Related Macular Degeneration Drug (Volume, Value and Sales Price)

5.1 Europe Age Related Macular Degeneration Drug Sales and Value (2011-2016)

5.1.1 Europe Age Related Macular Degeneration Drug Sales and Growth Rate (2011-2016)

5.1.2 Europe Age Related Macular Degeneration Drug Revenue and Growth Rate (2011-2016)

5.1.3 Europe Age Related Macular Degeneration Drug Sales Price Trend (2011-2016)

5.2 Europe Age Related Macular Degeneration Drug Sales and Market Share by Manufacturers

5.3 Europe Age Related Macular Degeneration Drug Sales and Market Share by Type

5.4 Europe Age Related Macular Degeneration Drug Sales and Market Share by Application

6 Japan Age Related Macular Degeneration Drug (Volume, Value and Sales Price)

6.1 Japan Age Related Macular Degeneration Drug Sales and Value (2011-2016)

6.1.1 Japan Age Related Macular Degeneration Drug Sales and Growth Rate (2011-2016)

6.1.2 Japan Age Related Macular Degeneration Drug Revenue and Growth Rate (2011-2016)

6.1.3 Japan Age Related Macular Degeneration Drug Sales Price Trend (2011-2016)

6.2 Japan Age Related Macular Degeneration Drug Sales and Market Share by Manufacturers

6.3 Japan Age Related Macular Degeneration Drug Sales and Market Share by Type

6.4 Japan Age Related Macular Degeneration Drug Sales and Market Share by Application

7 India Age Related Macular Degeneration Drug (Volume, Value and Sales Price)

7.1 India Age Related Macular Degeneration Drug Sales and Value (2011-2016)

7.1.1 India Age Related Macular Degeneration Drug Sales and Growth Rate (2011-2016)

7.1.2 India Age Related Macular Degeneration Drug Revenue and Growth Rate (2011-2016)

7.1.3 India Age Related Macular Degeneration Drug Sales Price Trend (2011-2016)

7.2 India Age Related Macular Degeneration Drug Sales and Market Share by Manufacturers

7.3 India Age Related Macular Degeneration Drug Sales and Market Share by Type

7.4 India Age Related Macular Degeneration Drug Sales and Market Share by Application

8 Southeast Asia Age Related Macular Degeneration Drug (Volume, Value and Sales Price)

8.1 Southeast Asia Age Related Macular Degeneration Drug Sales and Value (2011-2016)

8.1.1 Southeast Asia Age Related Macular Degeneration Drug Sales and Growth Rate (2011-2016)

8.1.2 Southeast Asia Age Related Macular Degeneration Drug Revenue and Growth Rate (2011-2016)

8.1.3 Southeast Asia Age Related Macular Degeneration Drug Sales Price Trend (2011-2016)

8.2 Southeast Asia Age Related Macular Degeneration Drug Sales and Market Share by Manufacturers

8.3 Southeast Asia Age Related Macular Degeneration Drug Sales and Market Share by Type

8.4 Southeast Asia Age Related Macular Degeneration Drug Sales and Market Share by Application

9 Global Age Related Macular Degeneration Drug Manufacturers Analysis

9.1 Roche/Genentech

9.1.1 Company Basic Information, Manufacturing Base and Competitors

9.1.2 Age Related Macular Degeneration Drug Product Type, Application and Specification

9.1.2.1 Type I

9.1.2.2 Type II

9.1.3 Roche/Genentech Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

9.1.4 Main Business/Business Overview

9.2 Novartis

9.2.1 Company Basic Information, Manufacturing Base and Competitors

9.2.2 128 Product Type, Application and Specification

9.2.2.1 Type I

9.2.2.2 Type II

9.2.3 Novartis Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

9.2.4 Main Business/Business Overview

9.3 Regeneron

9.3.1 Company Basic Information, Manufacturing Base and Competitors

9.3.2 144 Product Type, Application and Specification

9.3.2.1 Type I

9.3.2.2 Type II

9.3.3 Regeneron Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

9.3.4 Main Business/Business Overview

9.4 Bayer

9.4.1 Company Basic Information, Manufacturing Base and Competitors

9.4.2 Aug Product Type, Application and Specification

9.4.2.1 Type I

9.4.2.2 Type II

9.4.3 Bayer Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

9.4.4 Main Business/Business Overview

9.5 Valeant

9.5.1 Company Basic Information, Manufacturing Base and Competitors

9.5.2 Product Type, Application and Specification

9.5.2.1 Type I

9.5.2.2 Type II

9.5.3 Valeant Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

9.5.4 Main Business/Business Overview

9.6 Allergan

9.6.1 Company Basic Information, Manufacturing Base and Competitors

9.6.2 Million USD Product Type, Application and Specification

9.6.2.1 Type I

9.6.2.2 Type II

9.6.3 Allergan Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

9.6.4 Main Business/Business Overview

9.7 Alimera Sciences

9.7.1 Company Basic Information, Manufacturing Base and Competitors

9.7.2 Pharmaceuticals Product Type, Application and Specification

9.7.2.1 Type I

9.7.2.2 Type II

9.7.3 Alimera Sciences Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

9.7.4 Main Business/Business Overview

9.8 Ophthotech

9.8.1 Company Basic Information, Manufacturing Base and Competitors

9.8.2 Product Type, Application and Specification

9.8.2.1 Type I

9.8.2.2 Type II

9.8.3 Ophthotech Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

9.8.4 Main Business/Business Overview

9.9 Acucela

9.9.1 Company Basic Information, Manufacturing Base and Competitors

9.9.2 Product Type, Application and Specification

9.9.2.1 Type I

9.9.2.2 Type II

9.9.3 Acucela Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

9.9.4 Main Business/Business Overview

9.10 Ohr Pharmaceuticals

9.10.1 Company Basic Information, Manufacturing Base and Competitors

9.10.2 Product Type, Application and Specification

9.10.2.1 Type I

9.10.2.2 Type II

9.10.3 Ohr Pharmaceuticals Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

9.10.4 Main Business/Business Overview

10 Age Related Macular Degeneration Drug Maufacturing Cost Analysis

10.1 Age Related Macular Degeneration Drug Key Raw Materials Analysis

10.1.1 Key Raw Materials

10.1.2 Price Trend of Key Raw Materials

10.1.3 Key Suppliers of Raw Materials

10.1.4 Market Concentration Rate of Raw Materials

10.2 Proportion of Manufacturing Cost Structure

10.2.1 Raw Materials

10.2.2 Labor Cost

10.2.3 Manufacturing Process Analysis of Age Related Macular Degeneration Drug

11 Industrial Chain, Sourcing Strategy and Downstream Buyers

11.1 Age Related Macular Degeneration Drug Industrial Chain Analysis

11.2 Upstream Raw Materials Sourcing

11.3 Raw Materials Sources of Age Related Macular Degeneration Drug Major Manufacturers in 2015

11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders

12.1 Marketing Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.1.3 Marketing Channel Development Trend

12.2 Market Positioning

12.2.1 Pricing Strategy

12.2.2 Brand Strategy

12.2.3 Target Client

12.3 Distributors/Traders List

13 Market Effect Factors Analysis

13.1 Technology Progress/Risk

13.1.1 Substitutes Threat

13.1.2 Technology Progress in Related Industry

13.2 Consumer Needs/Customer Preference Change

13.3 Economic/Political Environmental Change

14 Global Age Related Macular Degeneration Drug Market Forecast (2016-2021)

14.1 Global Age Related Macular Degeneration Drug Sales, Revenue Forecast (2016-2021)

14.2 Global Age Related Macular Degeneration Drug Sales Forecast by Regions (2016-2021)

14.3 Global Age Related Macular Degeneration Drug Sales Forecast by Type (2016-2021)

14.4 Global Age Related Macular Degeneration Drug Sales Forecast by Application (2016-2021)

15 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

China Disclaimer

Figure Picture of Age Related Macular Degeneration Drug

Table Classification of Age Related Macular Degeneration Drug

Figure Global Sales Market Share of Age Related Macular Degeneration Drug by Type in 2015

Figure Type I Picture

Figure Type II Picture

Table Applications of Age Related Macular Degeneration Drug

Figure Global Sales Market Share of Age Related Macular Degeneration Drug by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure USA Age Related Macular Degeneration Drug Revenue and Growth Rate (2011-2021)

Figure China Age Related Macular Degeneration Drug Revenue and Growth Rate (2011-2021)

Figure Europe Age Related Macular Degeneration Drug Revenue and Growth Rate (2011-2021)

Figure Japan Age Related Macular Degeneration Drug Revenue and Growth Rate (2011-2021)

Figure India Age Related Macular Degeneration Drug Revenue and Growth Rate (2011-2021)

Figure Southeast Asia Age Related Macular Degeneration Drug Revenue and Growth Rate (2011-2021)

Figure Global Age Related Macular Degeneration Drug Sales and Growth Rate (2011-2021)

Figure Global Age Related Macular Degeneration Drug Revenue and Growth Rate (2011-2021)

Table Global Age Related Macular Degeneration Drug Sales of Key Manufacturers (2011-2016)

Table Global Age Related Macular Degeneration Drug Sales Share by Manufacturers (2011-2016)

Figure 2015 Age Related Macular Degeneration Drug Sales Share by Manufacturers

Figure 2016 Age Related Macular Degeneration Drug Sales Share by Manufacturers

Table Global Age Related Macular Degeneration Drug Revenue by Manufacturers (2011-2016)

Table Global Age Related Macular Degeneration Drug Revenue Share by Manufacturers (2011-2016)

Table 2015 Global Age Related Macular Degeneration Drug Revenue Share by Manufacturers

Table 2016 Global Age Related Macular Degeneration Drug Revenue Share by Manufacturers

Table Global Age Related Macular Degeneration Drug Sales and Market Share by Type (2011-2016)

Table Global Age Related Macular Degeneration Drug Sales Share by Type (2011-2016)

Figure Sales Market Share of Age Related Macular Degeneration Drug by Type (2011-2016)

Figure Global Age Related Macular Degeneration Drug Sales Growth Rate by Type (2011-2016)

Table Global Age Related Macular Degeneration Drug Revenue and Market Share by Type (2011-2016)

Table Global Age Related Macular Degeneration Drug Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Age Related Macular Degeneration Drug by Type (2011-2016)

Figure Global Age Related Macular Degeneration Drug Revenue Growth Rate by Type (2011-2016)

Table Global Age Related Macular Degeneration Drug Sales and Market Share by Regions (2011-2016)

Table Global Age Related Macular Degeneration Drug Sales Share by Regions (2011-2016)

Figure Sales Market Share of Age Related Macular Degeneration Drug by Regions (2011-2016)

Figure Global Age Related Macular Degeneration Drug Sales Growth Rate by Regions (2011-2016)

Table Global Age Related Macular Degeneration Drug Revenue and Market Share by Regions (2011-2016)

Table Global Age Related Macular Degeneration Drug Revenue Share by Regions (2011-2016)

Figure Revenue Market Share of Age Related Macular Degeneration Drug by Regions (2011-2016)

Figure Global Age Related Macular Degeneration Drug Revenue Growth Rate by Regions (2011-2016)

Table Global Age Related Macular Degeneration Drug Sales and Market Share by Application (2011-2016)

Table Global Age Related Macular Degeneration Drug Sales Share by Application (2011-2016)

Figure Sales Market Share of Age Related Macular Degeneration Drug by Application (2011-2016)

Figure Global Age Related Macular Degeneration Drug Sales Growth Rate by Application (2011-2016)

Figure USA Age Related Macular Degeneration Drug Sales and Growth Rate (2011-2016)

Figure USA Age Related Macular Degeneration Drug Revenue and Growth Rate (2011-2016)

Figure USA Age Related Macular Degeneration Drug Sales Price Trend (2011-2016)

Table USA Age Related Macular Degeneration Drug Sales by Manufacturers (2011-2016)

Table USA Age Related Macular Degeneration Drug Market Share by Manufacturers (2011-2016)

Table USA Age Related Macular Degeneration Drug Sales by Type (2011-2016)

Table USA Age Related Macular Degeneration Drug Market Share by Type (2011-2016)

Table USA Age Related Macular Degeneration Drug Sales by Application (2011-2016)

Table USA Age Related Macular Degeneration Drug Market Share by Application (2011-2016)

Figure China Age Related Macular Degeneration Drug Sales and Growth Rate (2011-2016)

Figure China Age Related Macular Degeneration Drug Revenue and Growth Rate (2011-2016)

Figure China Age Related Macular Degeneration Drug Sales Price Trend (2011-2016)

Table China Age Related Macular Degeneration Drug Sales by Manufacturers (2011-2016)

Table China Age Related Macular Degeneration Drug Market Share by Manufacturers (2011-2016)

Table China Age Related Macular Degeneration Drug Sales by Type (2011-2016)

Table China Age Related Macular Degeneration Drug Market Share by Type (2011-2016)

Table China Age Related Macular Degeneration Drug Sales by Application (2011-2016)

Table China Age Related Macular Degeneration Drug Market Share by Application (2011-2016)

Figure Europe Age Related Macular Degeneration Drug Sales and Growth Rate (2011-2016)

Figure Europe Age Related Macular Degeneration Drug Revenue and Growth Rate (2011-2016)

Figure Europe Age Related Macular Degeneration Drug Sales Price Trend (2011-2016)

Table Europe Age Related Macular Degeneration Drug Sales by Manufacturers (2011-2016)

Table Europe Age Related Macular Degeneration Drug Market Share by Manufacturers (2011-2016)

Table Europe Age Related Macular Degeneration Drug Sales by Type (2011-2016)

Table Europe Age Related Macular Degeneration Drug Market Share by Type (2011-2016)

Table Europe Age Related Macular Degeneration Drug Sales by Application (2011-2016)

Table Europe Age Related Macular Degeneration Drug Market Share by Application (2011-2016)

Figure Japan Age Related Macular Degeneration Drug Sales and Growth Rate (2011-2016)

Figure Japan Age Related Macular Degeneration Drug Revenue and Growth Rate (2011-2016)

Figure Japan Age Related Macular Degeneration Drug Sales Price Trend (2011-2016)

Table Japan Age Related Macular Degeneration Drug Sales by Manufacturers (2011-2016)

Table Japan Age Related Macular Degeneration Drug Market Share by Manufacturers (2011-2016)

Table Japan Age Related Macular Degeneration Drug Sales by Type (2011-2016)

Table Japan Age Related Macular Degeneration Drug Market Share by Type (2011-2016)

Table Japan Age Related Macular Degeneration Drug Sales by Application (2011-2016)

Table Japan Age Related Macular Degeneration Drug Market Share by Application (2011-2016)

Figure India Age Related Macular Degeneration Drug Sales and Growth Rate (2011-2016)

Figure India Age Related Macular Degeneration Drug Revenue and Growth Rate (2011-2016)

Figure India Age Related Macular Degeneration Drug Sales Price Trend (2011-2016)

Table India Age Related Macular Degeneration Drug Sales by Manufacturers (2011-2016)

Table India Age Related Macular Degeneration Drug Market Share by Manufacturers (2011-2016)

Table India Age Related Macular Degeneration Drug Sales by Type (2011-2016)

Table India Age Related Macular Degeneration Drug Market Share by Type (2011-2016)

Table India Age Related Macular Degeneration Drug Sales by Application (2011-2016)

Table India Age Related Macular Degeneration Drug Market Share by Application (2011-2016)

Figure Southeast Asia Age Related Macular Degeneration Drug Sales and Growth Rate (2011-2016)

Figure Southeast Asia Age Related Macular Degeneration Drug Revenue and Growth Rate (2011-2016)

Figure Southeast Asia Age Related Macular Degeneration Drug Sales Price Trend (2011-2016)

Table Southeast Asia Age Related Macular Degeneration Drug Sales by Manufacturers (2011-2016)

Table Southeast Asia Age Related Macular Degeneration Drug Market Share by Manufacturers (2011-2016)

Table Southeast Asia Age Related Macular Degeneration Drug Sales by Type (2011-2016)

Table Southeast Asia Age Related Macular Degeneration Drug Market Share by Type (2011-2016)

Table Southeast Asia Age Related Macular Degeneration Drug Sales by Application (2011-2016)

Table Southeast Asia Age Related Macular Degeneration Drug Market Share by Application (2011-2016)

Table Roche/Genentech Basic Information List

Table Roche/Genentech Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Roche/Genentech Age Related Macular Degeneration Drug Global Market Share (2011-2016)

Table Novartis Basic Information List

Table Novartis Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Novartis Age Related Macular Degeneration Drug Global Market Share (2011-2016)

Table Regeneron Basic Information List

Table Regeneron Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Regeneron Age Related Macular Degeneration Drug Global Market Share (2011-2016)

Table Bayer Basic Information List

Table Bayer Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Bayer Age Related Macular Degeneration Drug Global Market Share (2011-2016)

Table Valeant Basic Information List

Table Valeant Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Valeant Age Related Macular Degeneration Drug Global Market Share (2011-2016)

Table Allergan Basic Information List

Table Allergan Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Allergan Age Related Macular Degeneration Drug Global Market Share (2011-2016)

Table Alimera Sciences Basic Information List

Table Alimera Sciences Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Alimera Sciences Age Related Macular Degeneration Drug Global Market Share (2011-2016)

Table Ophthotech Basic Information List

Table Ophthotech Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Ophthotech Age Related Macular Degeneration Drug Global Market Share (2011-2016)

Table Acucela Basic Information List

Table Acucela Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Acucela Age Related Macular Degeneration Drug Global Market Share (2011-2016)

Table Ohr Pharmaceuticals Basic Information List

Table Ohr Pharmaceuticals Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Ohr Pharmaceuticals Age Related Macular Degeneration Drug Global Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Age Related Macular Degeneration Drug

Figure Manufacturing Process Analysis of Age Related Macular Degeneration Drug

Figure Age Related Macular Degeneration Drug Industrial Chain Analysis

Table Raw Materials Sources of Age Related Macular Degeneration Drug Major Manufacturers in 2015

Table Major Buyers of Age Related Macular Degeneration Drug

Table Distributors/Traders List

Figure Global Age Related Macular Degeneration Drug Sales and Growth Rate Forecast (2016-2021)

Figure Global Age Related Macular Degeneration Drug Revenue and Growth Rate Forecast (2016-2021)

Table Global Age Related Macular Degeneration Drug Sales Forecast by Regions (2016-2021)

Table Global Age Related Macular Degeneration Drug Sales Forecast by Type (2016-2021)

Table Global Age Related Macular Degeneration Drug Sales Forecast by Application (2016-2021)